FRI0534 PATIENT-REPORTED MEASURES OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS VARY ACROSS THE NORDIC COUNTRIES, RESULTS FROM A NORDIC COLLABORATION

• Published in: Annals of the Rheumatic Diseases
• Main Authors: Delcoigne, B., Aarrestad Provan, S., Hammer, H. B., DI Giuseppe, D., Frisell, T., Glintborg, B., Gröndal, G., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Nordström, D., Relas, H., Steen Krogh, N., Askling, J.
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMJ 2020
• Subjects: General Biochemistry, Genetics and Molecular Biology; Immunology; Immunology and Allergy; Rheumatology; Norway; Orion; Steen; Michelsen; Krogh; Iceland
• Online Access: http://dx.doi.org/10.1136/annrheumdis-2020-eular.3363; https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2020-eular.3363

Background: Disease activity in rheumatoid arthritis (RA) patients is measured through composite scores which are considered treatment targets and thus facilitate clinical decision making. Scores often combine a mix of objective and subjective measures, and, although the latter (e.g. pain, patient’s...